Top

Published in:

01-06-2017 | Review

Prognosis of pregnancy-associated breast cancer

Authors: Guek Eng Lee, Erica L. Mayer, Ann Partridge

Published in: Breast Cancer Research and Treatment | Issue 3/2017

Abstract

Conventionally, breast cancer diagnosed during pregnancy and within the years following have been referred to collectively as pregnancy-associated breast cancer. However, increasing evidence suggests that breast cancer diagnosed during pregnancy is a different entity from that diagnosed postpartum, both in terms of prognosis and biology. Given the increasing number of women who find themselves diagnosed with breast cancer during or following a pregnancy, future research and discussion should separate these two into distinct groups: breast cancer diagnosed during pregnancy and breast cancer diagnosed postpartum in an effort to enhance our understanding to inform and improve clinical management and counseling.

Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128–1135CrossRefPubMed

Van Calsteren K et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689CrossRefPubMed

Andersson TM et al (2009) Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 114(3):568–572CrossRefPubMed

Raphael J, Trudeau ME, Chan K (2015) Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol 22(Suppl 1):S8–S18PubMedPubMedCentral

Abenhaim HA et al (2012) Incidence, risk factors, and obstetrical outcomes of women with breast cancer in pregnancy. Breast J 18(6):564–568CrossRefPubMed

Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6(4):281–291CrossRefPubMed

Vinatier E et al (2009) Breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 147(1):9–14CrossRefPubMed

Psyrri A, Burtness B (2005) Pregnancy-associated breast cancer. Cancer J 11(2):83–95CrossRefPubMed

Lyons TR, Schedin PJ, Borges VF (2009) Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14(2):87–98CrossRefPubMedPubMedCentral

10.

Borges VF, Schedin PJ (2012) Pregnancy-associated breast cancer. Cancer 118(13):3226–3228CrossRefPubMed

11.

Amant F et al (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539CrossRefPubMed

12.

Azim HA Jr et al (2012) The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol 51(5):653–661CrossRefPubMed

13.

Azim HA Jr et al (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38(7):834–842CrossRefPubMed

14.

Litton JK et al (2013) Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 18(4):369–376CrossRefPubMedPubMedCentral

15.

Ezzat A et al (1996) Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 8(6):367–370CrossRef

16.

Greene FL (1988) Gestational breast cancer: a ten-year experience. South Med J 81(12):1509–1511CrossRefPubMed

17.

Guinee VF et al (1994) Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343(8913):1587–1589CrossRefPubMed

18.

Ibrahim EM et al (2000) Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 17(4):293–300CrossRefPubMed

19.

Nugent P, O’Connell TX (1985) Breast cancer and pregnancy. Arch Surg 120(11):1221–1224CrossRefPubMed

20.

Stensheim H et al (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51CrossRefPubMed

21.

Tretli S et al (1988) Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer 58(3):382–384CrossRefPubMedPubMedCentral

22.

Hartman EK, Eslick GD (2016) The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res Treat 160(2):347–360CrossRefPubMed

23.

Amant F et al (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46(18):3158–3168CrossRefPubMed

24.

Loibl S et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237–246CrossRefPubMed

25.

O’Neill AC, DiPiro PJ, Mayer EL (2016) Staging workup in pregnant cancer patients, in managing cancer during pregnancy. In: Azim HA Jr (ed). Springer, New York, pp 17–28

26.

Callihan EB et al (2013) Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 138(2):549–559CrossRefPubMedPubMedCentral

27.

Johansson AL et al (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872CrossRefPubMed

28.

Daling JR et al (2002) The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev 11(3):235–241PubMed

29.

Whiteman MK et al (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104(1):146–154CrossRefPubMed

30.

Van den Rul N et al (2011) Postpartum breast cancer behaves differently. Facts Views Vis Obgyn 3(3):183–188PubMedPubMedCentral

31.

Barnett GC et al (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316CrossRefPubMed

32.

Asztalos S et al (2010) Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) 3(3):301–311CrossRef

33.

Atabai K, Sheppard D, Werb Z (2007) Roles of the innate immune system in mammary gland remodeling during involution. J Mammary Gland Biol Neoplasia 12(1):37–45CrossRefPubMedPubMedCentral

34.

Clarkson RW et al (2000) NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem 275(17):12737–12742CrossRefPubMed

35.

Clarkson RW et al (2004) Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6(2):R92–R109CrossRefPubMed

36.

Lyons TR et al (2014) Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. J Clin Investig 124(9):3901–3912CrossRefPubMedPubMedCentral

37.

Lyons TR et al (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109–1115CrossRefPubMedPubMedCentral

38.

Monks J et al (2002) Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia 7(2):163–176CrossRefPubMed

39.

O’Brien J, Schedin P (2009) Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14(2):145–157CrossRefPubMedPubMedCentral

40.

Schedin P et al (2004) Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 41(4):207–220CrossRefPubMed

41.

Borges V, Elder A, Lyons T (2016) Deciphering pro-lymphangiogenic programs during mammary involution and postpartum breast cancer. Front Oncol 6(227)

42.

Swartz MA (2014) Inflammatory lymphangiogenesis in postpartum breast tissue remodeling. J Clin Investig 124(9):3704–3707CrossRefPubMedPubMedCentral

43.

Borges VF et al (2015) Abstract P6-08-08: postpartum breast cancer demonstrates increased liver and brain metastasis with a proposed role for postpartum involution. Cancer Res 75(9 Supplement):P6–08-08-P6-08-08

44.

Collins LC et al (2015) Molecular phenotype of breast cancer according to time since last pregnancy in a large cohort of young women. Oncologist 20(7):713–718CrossRefPubMedPubMedCentral

Title: Prognosis of pregnancy-associated breast cancer
Authors: Guek Eng Lee
Erica L. Mayer
Ann Partridge
Publication date: 01-06-2017
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4224-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers

Chemotherapy-induced irreversible alopecia in early breast cancer patients

Self-reported long-term cardiac morbidity in breast cancer patients: a retrospective cohort study in Germany (PASSOS Heart Study)

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience

Keynote webinar | Spotlight on antibody–drug conjugates in cancer